申请人:Hoechst-Roussel Pharmaceuticals Inc.
公开号:US05340936A1
公开(公告)日:1994-08-23
This invention relates to compounds of the formula ##STR1## where X is --0--, --S--or --NH--; Y is hydrogen, halogen and loweralkoxy; p is 1 or 2; n is 2, 3 or 4; R is hydrogen, loweralkyl, loweralkoxy, hydroxy, halogen, amino, loweralkylamino, nitro, loweralkylthio, trifiuoromethoxy, cyano, trifluoromethyl, ##STR2## where aryl is ##STR3## R.sub.1 is hydrogen, loweralkyl, loweralkoxy, halogen, hydroxy, carboxyl, loweralkylamino, nitro, loweralkylthio, cyano, and trifluoromethyl; m is 1 or 2; a pharmaceutically acceptable acid addition salt thereof and, where applicable the geometric and optical isomers and racemic mixtures thereof. The compounds and compositions of this invention are useful as antipsychotic agent, as 5-HT.sub.3 receptor antagonists and as inhibitors of the reuptake of serotonin.
本发明涉及以下式子的化合物:##STR1## 其中X是--0--,--S--或--NH--;Y是氢,卤素和低烷氧基;p为1或2;n为2、3或4;R是氢,低烷基,低烷氧基,羟基,卤素,
氨基,低烷基
氨基,硝基,低烷基
硫基,三
氟甲氧基,
氰基,三
氟甲基,##STR2## 其中芳基是##STR3## R.sub.1是氢,低烷基,低烷氧基,卤素,羟基,羧基,低烷基
氨基,硝基,低烷基
硫基,
氰基和三
氟甲基;m为1或2;以及其药学上可接受的酸加合物,适用于
抗精神病药物,作为5-HT.sub.3受体拮抗剂和抑制
血清素再摄取的
抑制剂的化合物和组合物。